Microgenics' history is replete with technical innovations and breakthroughs. In June 1999, Microgenics merged with Diagnostic Reagents, Inc.
As one of the first diagnostic companies to harness the power of genetic engineering, Microgenics opened the door to a new generation of diagnostic assays. Microgenics marketed its first diagnostic products in 1986, based on its patented, bioengineered, non-isotopic CEDIA® technology. (DRI®), creating a leading immunoassay reagent manufacturer with a unique, comprehensive menu of tests using multi